OCULIS
Summary
Oculis is a late-stage biopharmaceutical company focused on developing transformative ophthalmic treatments to improve the sight and lives of patients.
Deals Overview
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
Senior Management
Riad Sherif
CEO
Sylvia Cheung
CFO
Louie-Anne Gauthier
VP Strategic Marketing